ESTRO 2024 - Abstract Book

S5037

Physics - Radiomics, functional and biological imaging and outcome prediction

ESTRO 2024

References:

1. Mike Partridge, Tokihiro Yamamoto, Cai Grau, Morten Høyer & Ludvig Paul Muren (2010) Imaging of normal lung, liver and parotid gland function for radiotherapy, Acta Oncologica, 49:7, 997-1011, DOI: 10.3109/0284186X.2010.504735

2. Eugene J. Koay, Dawn Owen & Pragnan Das (2018) Radiation-Induced Liver Disease and Modern Radiotherapy, Seminars in Radiation Oncology, 28:4, 321-331, DOI: 10.1016/j.semradonc.2018.06.007

3. Damian J. Mole, Jonathan A. Fallowfield, Ahmed E. Sherif et al. (2020) Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer, PLoS ONE, 15:12, DOI: 10.1371/journal.pone.0238568 4. Anneli Andersson, Matt Kelly, Kento Imajo et al. (2022) Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta Analysis, Clin Gastroenterol Hepatol, 20:11, 2451-2461, DOI: 10.1016/j.cgh.2021.09.041 5. A. Mojthed, C. J. Kelly, A. H. Herlihy et al. (2019) Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases, Abdom Radiol (NY), 44:1, 72-84, DOI: 10.1007/s00261-018-1701-2

1378

Proffered Paper

Genetically-based analysis of dose surface maps for assessing toxicity post-RT: an innovative method

Eliana Gioscio 1 , Michela Carlotta Massi 2,3 , Nicola Rares Franco 2 , Petra Seibold 4 , Barbara Avuzzi 5 , Alessandro Cicchetti 1 , Barry Rosenstein 6 , David Azria 7,8 , Ananya Choudhury 9,10 , Dirk De Ruysscher 11 , Maarten Lambrecht 12,13 , Elena Sperk 14 , Christopher J. Talbot 15 , Ana Vega 16 , Liv Veldeman 17 , Adam Webb 18 , Paolo Zunino 2 , Anna Maria Paganoni 2 , Francesca Ieva 2,3 , Andrea Manzoni 2 , Sarah L. Kerns 19 , Alison Dunning 20 , Jenny Chang-Claude 21,22 , Catharine M. L. West 23 , Tiziana Rancati 1 1 Fondazione IRCCS Istituto Nazionale dei Tumori, Data Science Unit, Milan, Italy. 2 Politecnico di Milano, MOX, Department of Mathematics, Milan, Italy. 3 Human Technopole, HDSD, Health Data Science Centre, Milan, Italy. 4 German Cancer Research Center (DKFZ)), Division of Cancer Epidemiology, Heidelberg, Germany. 5 Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Radiation Oncology, Milan, Italy. 6 Icahn School of Medicine at Mount Sinai, Department of Radiation Oncology and Department of Genetics and Genomic Sciences, New York, USA. 7 Université de Montpellier, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France. 8 Institut du Cancer de Montpellier (ICM), Department of Radiation Oncology, Montpellier, France. 9 University of Manchester Faculty of Biology Medicine and Health, Division of Cancer Sciences, Manchester, United Kingdom. 10 The Christie Hospital NHS Trust, Department of Clinical Oncology, Manchester, United Kingdom. 11 Maastricht University Medical Centre, Department of Radiation Oncology (Maastro), School for Oncology and Developmental Biology (Grow)), Maastricht, Netherlands. 12 University Hospitals Leuven, Department of Radiotherapy, Leuven, Belgium. 13 Katholieke